Development and validation of a claim-based provider-level measurement of use of medications to treat opioid use disorder
Journal of Substance Abuse Treatment(2022)
Abstract
•This study introduces a provider-level, claims-based measure of MOUD provision.•38 % of Medicaid patients with opioid use disorder received medication.•The interquartile ranges were 11 %–79 % (clinicians) and 9 %–45 % (facilities).•The measure reliably distinguished between higher- and lower-performing providers.•Measure scores were inversely correlated with SUD-related hospitalizations.
MoreTranslated text
Key words
Opioid use disorder,Medications for opioid use disorder,Claims-based quality measurement,Reliability,Validity
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined